Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combizym for Prevention of Functional Dyspepsia in Older Adults
ChiCTR-IPR-16008185Phase 4Recruiting
- Sponsor
- Committee of Geriatric Gastroenterology of the Chinese Society of Gastroenterology
- Start
- Apr 2016
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of Aspergillus oryzae + Pancreatin in functional dyspepsia (FD) (3 arms), sponsored by Committee of Geriatric Gastroenterology of the Chinese Society of Gastroenterology. Primary endpoints: Epigastric pain, Epigastric discomfort and 14 more. Started Apr 2016; status: recruiting.
02
Drugs
Aspergillus oryzae + Pancreatin
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on ChiCTR-IPR-16008185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008185.